Metacognitive Intervention for Individuals With Severe Mental Disorders

The overall aim of this study was to develop a meta-cognitive group intervention in order to apply it and to understand and distinguish the components that influence participation among people with schizophrenia

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Schizophrenia Mental Disorders Schizophrenia Spectrum and Other Psychotic Disorders

Age range

23 year–68 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

About this study

The overall aim of this study was to develop a Meta cognitive group intervention in order to apply it and to understand and distinguish the components that influence participation among people with schizophrenia. The specific objectives were to:

Improve participation by increasing the effectiveness of cognitive strategy use and teaching clients to independently review performance and to examine the strategy's effectiveness.
Compare the use of cognitive strategies between participants with schizophrenia and their matched controls following the Meta cognitive group intervention and to correlate the cognitive strategies use and participation following the Meta cognitive group.
Examine whether symptoms moderate the association between metacognitive outcomes and participation among people with schizophrenia following the Meta cognitive group.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Confirmed diagnosis of schizophrenia by a licensed psychiatrist
Fluency in Hebrew
t-score of at least 65 on the Behavior Rating Inventory of Executive Function-Adult version

Exclusion criteria

Severe psychiatric hospitalization of over 24 hours during the month prior to the beginning of the study
Used drugs or alcohol

Treatment and study plan

Metacognitive Group Intervention

Behavioral

The investigators developed an initial Meta cognitive group intervention protocol based on the dynamic interactional model of cognition (Toglia, 2005), and specifically tailored it to individuals with schizophrenia.

Occupational therapy standard care

Behavioral

Occupational therapy standard care

Primary outcomes

Positive and Negative Syndrome Scale

Time frame: 15 minutes

The Positive and Negative Syndrome Scale is a 30-item scale with seven positive and seven negative symptoms items and 16 psychopathological items. The severity of each item is rated on a scale from 1 (none) to 7 (most severe). A general Positive and Negative Syndrome Scale score is between 30 (lack of symptoms) and 210 (very severe state of the disease). Potential ranges are 7 to 49 for the positive and negative symptom scales and from 16 to 12 for the general psychopathology scale.

Sponsors and collaborators

Lead sponsor

University of Haifa

Other

Registry information

Official study title

Development and Efficacy of Metacognitive Intervention for Individuals With Severe Mental Disorders

Important dates

Study start: 2015
Primary completion: 2016
Study completion: 2016
First posted: Sep 27, 2022
Registry last updated: Oct 3, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed